Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Turnstone Biologics Corp. - Common Stock
(NQ:
TSBX
)
2.365
UNCHANGED
Streaming Delayed Price
Updated: 3:59 PM EDT, Aug 6, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
2.365
Bid (Size)
2.280 (4)
Ask (Size)
2.370 (6)
Prev. Close
2.365
Today's Range
2.365 - 2.365
52wk Range
1.625 - 12.80
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
12 Health Care Stocks Moving In Monday's After-Market Session
May 20, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
May 16, 2024
Via
Benzinga
Performance
YTD
-8.69%
-8.69%
1 Month
+4.65%
+4.65%
3 Month
-26.09%
-26.09%
6 Month
-1.05%
-1.05%
1 Year
-79.96%
-79.96%
More News
Read More
TSBX Stock Earnings: Turnstone Biologics Misses EPS for Q1 2024
May 13, 2024
Via
InvestorPlace
Turnstone Biologics Corp. Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights
May 13, 2024
From
Turnstone Biologics Corp.
Via
GlobeNewswire
Turnstone Biologics to Present at the 2024 Bank of America Securities Health Care Conference
May 08, 2024
From
Turnstone Biologics Corp.
Via
GlobeNewswire
Turnstone Biologics Appoints William Waddill to its Board of Directors
April 16, 2024
From
Turnstone Biologics Corp.
Via
GlobeNewswire
TSBX Stock Earnings: Turnstone Biologics Beats EPS for Q4 2023
March 22, 2024
Via
InvestorPlace
Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Recent Business Highlights
March 21, 2024
From
Turnstone Biologics Corp.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
March 19, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
March 08, 2024
Via
Benzinga
Turnstone Biologics to Participate in Upcoming Investor Conferences
February 21, 2024
From
Turnstone Biologics Corp.
Via
GlobeNewswire
Turnstone Biologics Announces the Passing of Chief Legal Officer P. Joseph Campisi, Jr., Esq.
February 20, 2024
From
Turnstone Biologics Corp.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
February 09, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
January 23, 2024
Via
Benzinga
Turnstone Biologics to Participate in the Piper Sandler 35th Annual Healthcare Conference
November 27, 2023
From
Turnstone Biologics Corp.
Via
GlobeNewswire
Turnstone Biologics Corp. Reports Third Quarter 2023 Financial Results and Provides Recent Business Highlights
November 09, 2023
From
Turnstone Biologics Corp.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
November 03, 2023
Via
Benzinga
Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2023 Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 03, 2023
From
Turnstone Biologics Corp.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
November 01, 2023
Via
Benzinga
Turnstone Biologics Expands Scientific Advisory Board with Appointment of Dr. Jeffrey S. Weber
October 30, 2023
From
Turnstone Biologics Corp.
Via
GlobeNewswire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
October 10, 2023
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's Intraday Session
October 09, 2023
Via
Benzinga
Why ParaZero Technologies Shares Are Trading Higher By Over 100%? Here Are Other Stocks Moving In Monday's Mid-Day Session
October 09, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
October 03, 2023
Via
Benzinga
Turnstone Biologics to Present Preclinical Data for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy at Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting
September 28, 2023
From
Turnstone Biologics Corp.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.